GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » LungLife AI Inc (LSE:LLAI) » Definitions » Tax Provision

LungLife AI (LSE:LLAI) Tax Provision : £-0.01 Mil (TTM As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is LungLife AI Tax Provision?

LungLife AI's tax provision for the six months ended in Dec. 2023 was £-0.00 Mil. Its tax provision for the trailing twelve months (TTM) ended in Dec. 2023 was £-0.01 Mil.

LungLife AI Tax Provision Historical Data

The historical data trend for LungLife AI's Tax Provision can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LungLife AI Tax Provision Chart

LungLife AI Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Tax Provision
Get a 7-Day Free Trial - - -0.01 - -0.01

LungLife AI Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Tax Provision Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.01 - - - -

LungLife AI Tax Provision Calculation

Tax to be paid.

Tax Provision for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was £-0.01 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LungLife AI (LSE:LLAI) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » LungLife AI Inc (LSE:LLAI) » Definitions » Tax Provision
Comparable Companies
LSE:PRM LSE:AGL LSE:ABDX LSE:VRCI LSE:GDR LSE:GENI LSE:DXRX TMO DHR SHSE:603259 IQV IDXX A XSWX:LONN MTD ICLR LH ILMN DGX WAT
Traded in Other Exchanges
N/A
Address
2545 W. Hillcrest Drive, Suite 140, Thousand Oaks, CA, USA, 91320
Website
https://www.lunglifeai.com
LungLife AI Inc is a diagnostic company focused on the early detection of lung cancer from a simple blood draw enhanced by artificial intelligence. Its LungLB Test is a blood-based tool developed to provide clinicians the information needed to make informed decisions about the management of lung nodules and lung cancer.

LungLife AI (LSE:LLAI) Headlines

No Headlines